Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-011336
Filing Date
2023-04-17
Accepted
2023-04-17 21:12:44
Documents
1
Period of Report
2023-04-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3849
  Complete submission text file 0000899243-23-011336.txt   5265
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELULARITY INC. 170 PARK AVENUE FLORHAM PARK NJ 07932
Business Address
Glover Bradley (Reporting) CIK: 0001867698 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38914 | Film No.: 23825284